Puriblood Medical Co., Ltd.

NT$71.10As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6847Healthcare
Country Taiwan
PE (Fwd) •••
TSR 5Y CAGR (16.72%)
Div yield —
ROE (40.92%)
Diagnostics & Research
Beta (5Y) 0.14
PE TTM —
TSR TTM (4.88%)
Mkt cap NT$1.012B
ROIC (40.98%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$89
25.13%
(18.50%)
Hold 0|9|6|4|5
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
1.07
1.18
1.21
1.24
(1.56%)
5.88%
11.49%
16.44%
RevenueNT$M
46.29
45.86
46.75
49.22
(0.71%)
(4.09%)
(1.56%)
4.15%
Peers (US$30.56M)
Cap (US$)
PE
28.26M
52.31x
21.39M
102.4x
Capital
TTM
5Y
10Y
Leveragex
0.199
0.132
0.135
EBIT/Intx
10.94
0.263
0.256
Own earn%
(55.33)
67.14
79.60
Sh yield%
35.75
38.54
38.64
Owners
Insiders/Inst%
10.46
74.46
Short interest%
4.31
SBC / revenue%
1.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
16–22
$1 testx
—
Incr. ROIC%
12